Computer-assisted Fetal Monitoring - Obstetrics
Launched by UNIVERSITY HOSPITAL, GRENOBLE · Feb 25, 2019
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
To monitor the well-being of a fetus or for a clinical diagnosis, a challenge is to extract a fetal electrocardiogram (fECG) signal of high quality from a limited number of non-invasive sensors on the maternal abdomen.
During childbirth, fetal monitoring is assessed by the fetal heart rate (FHR), classically from cardiotocography (CTG). The aim is to monitor FHR variability anomalies that reflect a too high fetal malaise. It is very common to have difficulties to reliably record FHR due to confusion of rhythms of the mother and the fetus that can lead to unnecessary caesareans. With 800000...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant of a single pregnancy,
- • Aged over 18,
- • During the 9th month of pregnancy (\>= 37 weeks),
- • With uncomplicated maternal and fetal pregnancy follow-up,
- • With a BMI between 18.5 and 30 at the beginning of pregnancy,
- • Without a notable medical history,
- • Enrolled in a social security scheme,
- • Having signed the consent form for the study.
- Exclusion Criteria:
- • Subject under guardianship, protected by law or deprived of liberty (Article L1121-8),
- • Subject under administrative or judicial supervision,
- • Subject in exclusion period of another study,
- • With toxic consumption (i.e. tobacco, alcohol, cannabis),
- • With inaccurate pregnancy term,
- • With denial of pregnancy.
About University Hospital, Grenoble
The University Hospital of Grenoble is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to facilitate cutting-edge studies that aim to improve treatment outcomes and enhance patient safety. With a strong commitment to collaboration, the University Hospital of Grenoble engages in partnerships with academic institutions, industry leaders, and regulatory bodies to drive scientific discovery and translate research findings into clinical practice. Its state-of-the-art facilities and multidisciplinary teams ensure rigorous adherence to ethical standards and regulatory guidelines, fostering an environment where groundbreaking research can thrive.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Grenoble, , France
Patients applied
Trial Officials
Véronique Equy
Principal Investigator
CHU Grenoble Alpes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials